Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10m Series A financing round led by Mercia, which will be used to scale operations and continue development of its DNA synthesis platform, gSynth™ . Click to read more.
Camena Bioscience Closes $10m Series A Financing as Demand for DNA Synthesis Technology Increases streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.